BioPharma Mexico is where experts like GE Healthcare Life Science's Andre Mindlin gather to network, learn from each other, and discuss the latest biopharma strategies and technology.

GE Healthcare Life Sciences on Biopharmaceutical Quality, Speed, and Cost

We were glad to have Andre Mindlin, General Manager for Latin America at GE Healthcare Life Sciences, present at last year’s BioPharma Mexico. You can now download his presentation slides from the event, where he addressed quality, speed, and cost control for the biopharmaceuticals of the future. Andre participated in the section of the event that focused on development of …

Dr Reddy’s launches antibiotic drug in US market

Dr Reddy’s Laboratories has launched Moxifloxacin Hydrochloride tablets in the US market for the treatment of diseases including pneumonia, bronchitis and skin infections. It was approved by the United States Food and Drug Administration, amidst the tightened regulations by the FDA on Indian exports. The tablets are a generic version of Avelox. Bayer’s Avelox is for the treatment of community …

GPCB issues closure notice to Zydus Cadila research unit

Gujarat Pollution Control Board (GPCB) has issues a closure notice to Zydus Cadila’s research unit in Ahmedabad for allegedly polluting ground water. They received a complaint from people that their unit at Moraiya area has been discharging polluted effluents to ground water. Upon receiving the complaints, GPCB officials inspected the area and found the irregularities, violating provisions of the Prevention …

Sun Pharma to acquire Ranbaxy

Sun Pharmaceutical Industries and Ranbaxy Laboratories have recently made an agreement to which Sun Pharma will acquire 100% of Ranbaxy in an all-stock transaction, meaning that Sun Pharma has effectively acquired Ranbaxy, a major player in Indian and US markets. Due to this acquisition, it creates the fifth-largest specialty generics company in the world and the largest pharmaceutical company in …

India’s Lupin queues up for a share of the biosimilar boom

Lupin is searching for partners to help bring it into the biosimilars market, aiming top-selling treatments with patents that are expiring soon. It already has 10 biosimilars products in development, with 5 in late-stage studies. Thus, it is looking for partners to help bring these products into the market. In addition to injectables for cancer and inflammatory disease, Lupin is …

US FDA Commissioner Margaret Hamburg met with Indian health regulators and pharma execs, saying she wanted to see more collaboration between FDA and Indian officials. However, India’s top drug regulator, G.N. Singh, the Drug Controller General of India, feels a little reluctant about adhering to all of FDA’s standards and expectations. He says that he sees some areas where the …

Teva’s New CEO Moves Quickly on Dealmaking

Recently, pharmaceutical company Teva has been facing numerous challenges. These include expiring patents for their top drugs, strong labour opposition to plans for restructuring, conflict between the Board of Directors and Management which resulted in the CEO’s departure, and shareholder unrest. Eyal Desheh, the CFO, has said that they have to make smart deals and partnerships like how Teva has …

Download: How to achieve an efficient cell culture process

    At last years BioPharma India conference Surendra Balekai, Sales Manager, BPP APAC, Thermo Fisher Scientific delivered the presentation:  Devising Methods to achieve an efficient cell culture process in Biomanufacturing. Click here to download this presentation This presentation explores: Top new technologies Approaches to  Media Optimization Metabolic Pathway Design Factorial Approach to Design An Optimizing Media Case Study Click …

Download Presentation: Understanding the strategies for delivering consistent operational excellence

In February 2013 over 250 delegates participated in the 3rd Annual Cell Culture World Congress at the Sofitel Bayerpost in Munich, Germany. This event focuses on the development and optimisation of cell culture bioproduction and explores the problem-points for each stage in the bio-production cycle. Attendees at this highly successful event were fortunate enough to hear this exciting presentation delivered …